P996: UTILITY OF KIT P.D816 IN MYELOID NEOPLASM WITHOUT DOCUMENTED SYSTEMIC MASTOCYTOSIS TO DETECT HIDDEN MAST CELLS IN BONE MARROW

P996: UTILITY OF KIT P.D816 IN MYELOID NEOPLASM WITHOUT DOCUMENTED SYSTEMIC MASTOCYTOSIS TO DETECT HIDDEN MAST CELLS IN BONE MARROW

Bibliographic Details
Main Authors:	D. H. Kim, F. Jia, C. Y. Ok
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846852.20639.bf

Similar Items

KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile
by: Marcelo A. S. de Toledo, et al.
Published: (2023-03-01)

Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.
by: Hoermann, G, et al.
Published: (2011)

Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic Mastocytosis
by: Nicole Naumann, et al.
Published: (2021-03-01)

Factor VII Deficiency in Systemic Mastocytosis with an Associated Myeloid Neoplasm
by: Giorgio Rosati, et al.
Published: (2024-03-01)

Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia
by: Lyndsey Sandow, et al.
Published: (2023-01-01)

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis
by: Geethani Bandara, et al.
Published: (2023-03-01)

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in <i>KIT</i> D816V-Negative Advanced Systemic Mastocytosis
by: Nicole Naumann, et al.
Published: (2024-01-01)

PB1815: T(8;16)(P11;P13): A RARE CASE OF ACUTE MYELOID LEUKEMIA
by: R. Cuccurullo, et al.
Published: (2022-06-01)

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
by: Clayton Webster Jackson, et al.
Published: (2021-10-01)

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS
by: D. J. DeAngelo, et al.
Published: (2022-06-01)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
by: Edyta Reszka, et al.
Published: (2021-03-01)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
by: Theo Gülen
Published: (2023-10-01)

Bone Marrow Mastocytosis: A Diagnostic Challenge
by: Roberta Zanotti, et al.
Published: (2021-04-01)

Eosinophilia in a patient with aggressive systemic mastocytosis harboring a D816V mutation: A case report
by: Lihong Cao, et al.
Published: (2023-08-01)

PD-L1 Expression in Mastocytosis
by: Margaret Williams, et al.
Published: (2019-05-01)

Educational Case: Systemic Mastocytosis with an Associated Hematological Neoplasm
by: Brenda Mai MD, et al.
Published: (2020-02-01)

P725: Molecular profile and associated prognosis in systemic mastocytosis with an associated hematologic neoplasm: A case report
by: Xiaolan Fang, et al.
Published: (2024-01-01)

Central Role of Mast Cells in Mastocytosis, Hereditary α-Tryptasemia, Mast Cell Activation Syndrome, Urticaria, and Angioedema
by: Michael Rudenko
Published: (2022-08-01)

P701: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
by: Athanasios Tasis, et al.
Published: (2023-08-01)

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
by: Linet Njue, et al.
Published: (2020-07-01)

Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
by: William Shomali, et al.
Published: (2021-03-01)

SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
by: Edwige Voisset, et al.
Published: (2020-07-01)

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY
by: A. Reiter, et al.
Published: (2022-06-01)

P994: HEDGEHOG PATHWAY INVOLVEMENT IN MASTOCYTOSIS DEVELOPMENT
by: L. Polivka, et al.
Published: (2022-06-01)

P386: CELL FATE DETERMINING TRANSCRIPTION FACTORS AS VULNERABILITIES IN CHILDHOOD AND ADULT MLL-REARRANGED AND T(8;16) ACUTE MYELOID LEUKEMIA
by: S. Arza Apalategi, et al.
Published: (2022-06-01)

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast Cells
by: Mathias Schneeweiss-Gleixner, et al.
Published: (2022-06-01)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
by: Siba El Hussein, et al.
Published: (2022-07-01)

Cisco CCNA/CCENT exam 640-802, 640-822, 640-816 preparation kit /
by: Liu, Dale.
Published: (c200)

P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
by: M. Castells, et al.
Published: (2022-06-01)

P996: A NOVEL GERMLINE GAIN-OF-FUNCTION JAK2 MUTATION: L604F
by: Lukas Dvoracek, et al.
Published: (2023-08-01)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
by: Mohammed O. A. Altohami, et al.
Published: (2021-08-01)

P691: MULTIOMIC SINGLE-CELL APPROACH REVEALED CLONAL ARCHITECTURE OF KIT MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS WITH/WITHOUT SYSTEMIC MASTOCYTOSIS
by: Yu-Hung Wang, et al.
Published: (2023-08-01)

P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS
by: A. Angi, et al.
Published: (2022-06-01)

Multiparticle correlation studies in pPb collisions at √SNN=8.16 TeV
by: CMS Collaboration, et al.
Published: (2020)

Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation
by: Lyndsey Sandow, et al.
Published: (2024-01-01)

P190: Validation of myeloid neoplasm next generation sequencing panel for acute myeloid leukemia and myeloid malignancies in Singapore
by: Than Hein, et al.
Published: (2023-01-01)

Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis
by: Roberta Sandra da Silva Tanizawa, et al.

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
by: Tobias Jürgen Schmidt, et al.
Published: (2022-07-01)

Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches
by: Marcelo L. Paiva, MPP, et al.
Published: (2023-06-01)

Systemic mastocytosis mimicking blastic plasmacytoid dendritic cell neoplasm: a case report
by: Xin Zhang, et al.
Published: (2023-02-01)